All groups had alveolar bone resorption.
各组均有牙槽骨吸收。
SOS was also negatively related to bone resorption markers.
骨超声声速与骨吸收指标呈负相关。
Therefore, insulin's effects on the bones favors bone resorption.
因此可以说，胰岛素对骨骼的影响促进了骨吸收的进程。
Alveolar bone resorption is the major reason of dysmasesia and dyspepsia.
牙槽骨吸收是导致临床咀嚼困难和失牙的主要原因。
From 6 to 12 months, the more bone resorption was observed in single crown group.
单冠修复组在6 ~12个月期间的种植体边缘骨吸收更为显著。
Due to its high potency, only small doses are necessary to inhibit bone resorption.
由于其强大的效力，只需很少的剂量就可以抑制骨的重吸收。
The inhibition of the differentiation and maturity of osteoclast will inhibit bone resorption.
抑制破骨细胞的分化成熟就能有效控制骨的吸收。
Conclusions Osteoclast-mediated bone resorption was inhibited by the bisphosphonate administration.
结论双膦酸盐对破骨细胞性骨吸收有明显的抑制作用。
Results: bone resorption was more obvious in alveolar bone with residual roots than that without roots.
结果：无牙根保留的牙槽骨吸收较有牙根保留的牙槽骨吸收明显。
If bone resorption is significant enough, then placement of an implant may become extremely challenging.
如果骨吸收显着足够，然后安置植入可能成为一个极具挑战性。
Objective To study the change of bone formation markers and bone resorption markers in women of different ages.
目的探讨骨吸收与形成指标在不同年龄组妇女中的变化趋势。
It is suggested that APD could directly suppress osteoclastic bone resorption and might be effective in osteoporosis.
提示APD具有较强的直接抑制破骨细胞性骨吸收的作用，对骨质疏松症可能有一定的疗效。
The results showed that the position and degrees of bone resorption had close relation to the position of denture bite.
结果表明骨吸收部位和程度与义齿咬合面的负荷位置关系密切。
X-ray showed new bone formation or no progressive bone resorption. The success rate was 100% during the follow-up period.
X线片示有新生骨形成或无渐进性骨吸收，随访期内成功率100%。
It appears that these factors are unique BRF, which are different from other known factors that can cause bone resorption.
实验结果表明此溶骨因子不同于其它已知能引起溶骨的因子。
The creeping substitution of the devitalized bone was mainly manifested by bone resorption within 12 weeks postoperatively.
术后12周以前，灭活骨段的爬行替代以骨吸收表现为主。
Periodontitis is an infectious diseases and the key feature is bone resorption, but the exact mechanism of etiology is unclear.
牙周炎是一类以牙槽骨吸收为主要特征的感染性疾病，但其病因理论中的许多具体机制尚未明了。
Conclusion: Nylestriol can inhibit expression of IL 6 mRNA, reduce osteoclastic bone resorption and decrease loss of bone mass.
结论：尼尔雌醇可以抑制IL6基因表达，从而抑制破骨细胞骨吸收，减少骨量丢失。
Results: Follow-up was between 3 to 12 months, the bone around the implants was better regained, and no progressive bone resorption.
结果经过3- 12个月随访，可见种植体周围无进行性骨吸收，种植体周围的骨量得到较好恢复。
And defects in the coupling of bone resorption and bone formation are accordant with the pathological process of modern medical diseases.
骨吸收与骨形成的偶联出现缺陷等，与现代医学疾病的病理过程相一致。
Summary of Background Data. Osteopetrosis is characterized by osteoclast dysfunction, impaired bone resorption, and poor bone remodeling.
石骨症的特征是破骨细胞功能出现障碍，使骨吸收减慢，导致骨再建缺陷。
CONCLUSION: RLX reduces bone turnover rate of the healthy Chinese postmenopausal women, inhibits bone resorption and prevents osteoporosis.
结论：盐酸雷洛昔芬可降低健康的中国绝经后妇女骨转换率，抑制骨吸收，可预防骨质疏松。
The bone resorption pits on bone slices were stained by toluidine blue and the resorption areas analyzed by computer image analysis software.
对骨片上形成的骨吸收陷窝进行甲苯胺蓝染色观察，并用计算机图像分析软件评估吸收面积的大小。
If the alveolar bone resorption can be controlled through inhibition of osteoclast, the anchorage teeth movement will be effectively managed.
如果能够控制破骨细胞的产生从而控制牙槽骨的吸收，就可以达到控制牙齿移动的目的。
Drugs that inhibit bone resorption [which are commonly used to treat osteoporosis] may, in certain patients, favor glucose intolerance, "Karsenty says."
而用于抑制骨吸收的各种药物(这些药物通常被用于治疗骨质疏松)有可能在一些特定的病人身上提升糖耐量。
Periodontal disease, seriously damaging human health, is the main reason for lost teeth. Alveolar bone resorption is the major pathological change.
牙周炎是危害人类健康的重要疾病之一，是造成失牙的最主要原因之一，牙槽骨吸收是其主要病理改变。
Results There was close relationship between the development of skeletal fluorosis and bone formation related gene and bone resorption related gene.
结果骨形成相关基因和骨吸收相关基因与氟骨症的发生密切相关。
The effect of ICD was stronger than that of APD. Conclusion ICD directly suppresses osteoclastic bone resorption and may be effective in osteoporosis.
结论ICD具有较强的直接抑制破骨细胞性骨吸收的作用，对骨质疏松症可能有一定的治疗作用。
Conclusion: XTTL Gel may alleviate bone cancer pain by inhibition of bone resorption and down regulation TRPV1 expression in the bone and hypothalamus.
结论：消痰通络凝胶可有效抑制骨癌痛，其治疗骨癌痛的机理可能与减少骨吸收、下调骨及下丘脑TRPV1的表达有关。
Conclusion: XTTL Gel may alleviate bone cancer pain by inhibition of bone resorption and down regulation TRPV1 expression in the bone and hypothalamus.
结论：消痰通络凝胶可有效抑制骨癌痛，其治疗骨癌痛的机理可能与减少骨吸收、下调骨及下丘脑TRPV1的表达有关。
应用推荐